Laboratory News and Research

RSS

SWOG selects four cancer researchers for 2011 Young Investigator Training Course

SWOG has selected four talented, early-career researchers for its 2011 Young Investigator Training Course. These four will attend a three-day workshop September 19 - 21 in Seattle, Wash., for intensive training in how to design and conduct cancer clinical trials.

3 Sep 2011

Roche Diagnostics terminates sales and distribution agreement with Response

Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.

From Roche Sequencing and Life Science 2 Sep 2011

Mayo Clinic and IC-MedTech enter collaborative research agreement with Summa Health System

Researchers from the Mayo Clinic and representatives from IC-MedTech signed a collaborative research agreement with Summa Health System to study the usage of Apatone, a proprietary combination of Vitamin-C and Vitamin-K3.

2 Sep 2011

New medicines to target LPA receptors may prevent serious developmental brain diseases

Examining brain damage that occurs when fetuses in the womb are deprived of oxygen, researchers at The Scripps Research Institute have discovered that damage does not occur randomly but is linked to the specific action of a naturally occurring fatty molecule called LPA, acting through a receptor that transfers information into young brain cells.

2 Sep 2011

Researchers modify toxic chemical of marine cycyanobacteria to treat colon cancer

University of Florida researchers have modified a toxic chemical produced by tiny marine microbes and successfully deployed it against laboratory models of colon cancer.

2 Sep 2011

Contraceptive pill prevents loss of eye sight

Scientists at University College Cork (UCC) have shown that the active component (Norgestrel) of the contraceptive 'Mini Pill' prevents the loss of sight in mice that have degenerative eye conditions that normally lead to blindness.

2 Sep 2011

Medi-Cal investigation of inflated bills yields settlement from Lab Corp.

Laboratory Corp. of America has agreed to pay $49.5 million to resolve a whistle-blower's allegations that the Burlington, N.C.-based company paid kickbacks to doctors and hospitals for referring California Medicaid patients, whose bills were then allegedly inflated.

2 Sep 2011

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

The September issue of the online scientific journal Acta Crystallographica: Structural Biology and Crystallization Communications (Acta Cryst F) will consist entirely of work done at the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of researchers from Seattle BioMed, Emerald BioStructures, the University of Washington and Pacific Northwest National Laboratory.

2 Sep 2011

CRI announces winners of 2011 Coley Award for distinguished research in tumor immunology

The Cancer Research Institute, Inc. (CRI), a U.S. nonprofit organization established in 1953 to advance the science of tumor immunology and drive the discovery of new cancer immunotherapies, announced today the winners of the 2011 William B. Coley Award for Distinguished Research in Tumor Immunology.

2 Sep 2011

Stanford method identifies essential regions of Caulobacter's genome

A team at the Stanford University School of Medicine has cataloged, down to the letter, exactly what parts of the genetic code are essential for survival in one bacterial species, Caulobacter crescentus.

31 Aug 2011

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Radiation can make cancer cells resistant to radio- and chemotherapy. University of Oslo researchers have now figured out how resistance can be switched on and off.

30 Aug 2011

Bristol-Myers Squibb selects ICON as preferred provider for early phase clinical development

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been chosen by Bristol-Myers Squibb Company as a preferred provider for full-service clinical pharmacology and exploratory clinical studies.

30 Aug 2011

Stent for Life Initiative aims to support implementation of primary PCI in the ESC countries

Primary PCI is the best reperfusion therapy for patients presenting with acute ST-elevation myocardial infarction. CJ Terkelsen and co-workers used the Western Denmark Heart Registry to describe the implementation of primary PCI in Denmark.

30 Aug 2011

An advance toward using stem cells in 'regenerative medicine'

With stem cells so fickle and indecisive that they make Shakespeare's Hamlet pale by comparison, scientists today described an advance in encouraging stem cells to make decisions about their fate.

30 Aug 2011

Educational program about cardiovascular prevention in children can reduce parents' CVD risk

"A multidisciplinary educational programme in cardiovascular prevention directed to children of school age can reduce their parents' cardiovascular risk. Cardiovascular prevention could have more success focusing on children first, inducing healthier lifestyle habits in the whole family, "said investigator Luciana Fornari, from the University of Sao Paulo, Brazil.

30 Aug 2011

New chemical compounds show promise against set of protein-folding diseases

Collaborating researchers at Stanford University and The Scripps Research Institute have identified chemical compounds that show promise as potential therapeutics for a set of medical conditions caused by the abnormal clumping together of a protein known as transthyretin.

30 Aug 2011

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

The Echocardiography and Vascular Laboratory at St. Michael's Hospital has been recognized for its commitment to quality patient care and testing for heart and vascular disease.

30 Aug 2011

Governor Perry attacked for choosing new medical treatment

Recently, the governor of Texas and presidential hopeful had a bad back treated by injecting some of his very own fat cells, after they had been cultured and treated in a laboratory. The innovative use of a patient’s own adult stem cells is showing great promise in many conditions, including damaged joints.

29 Aug 2011

Optical treatment strategies to correct peripheral vision may slow progression of myopia

New scientific evidence on how feedback from the eye affects visual development may lead to more effective approaches to treating myopia (nearsightedness) in children, reports a paper in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

29 Aug 2011

Cederquist Medical Wellness Center now offers state-of-the-art genetic testing

Cederquist Medical Wellness Center is now offering genetic testing which demonstrates how genetics influence a wide variety of behaviors relating to diet and weight control.

29 Aug 2011

Laboratory News and Research

SWOG selects four cancer researchers for 2011 Young Investigator Training Course

Roche Diagnostics terminates sales and distribution agreement with Response

Mayo Clinic and IC-MedTech enter collaborative research agreement with Summa Health System

New medicines to target LPA receptors may prevent serious developmental brain diseases

Researchers modify toxic chemical of marine cycyanobacteria to treat colon cancer

Contraceptive pill prevents loss of eye sight

Medi-Cal investigation of inflated bills yields settlement from Lab Corp.

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

CRI announces winners of 2011 Coley Award for distinguished research in tumor immunology

Stanford method identifies essential regions of Caulobacter's genome

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Bristol-Myers Squibb selects ICON as preferred provider for early phase clinical development

Stent for Life Initiative aims to support implementation of primary PCI in the ESC countries

An advance toward using stem cells in 'regenerative medicine'

Educational program about cardiovascular prevention in children can reduce parents' CVD risk

New chemical compounds show promise against set of protein-folding diseases

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

Governor Perry attacked for choosing new medical treatment

Optical treatment strategies to correct peripheral vision may slow progression of myopia

Cederquist Medical Wellness Center now offers state-of-the-art genetic testing

Lab Diagnostics and Automation - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News